Vaccibody to present 4 poster during AACR

Vaccibody AS has been accepted for an impressive 4 poster presentations at the annual meeting in the American Association for Cancer Research in April 2019. Two of the papers demonstrates the progress made with the unique Vaccibody platform and its ability to induce strong tumor protective immune responses alone and in combination with Nektar´s Lead Immuno-oncology Candidate (NKTR-214).

Read more